Medicare AdvantageCoverageMedium impact
MA11.056i, Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass Surgery
Independence Blue Cross·Vascular Surgery, Neurosurgery, Cardiology +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.056i regarding Percutaneous Transluminal Angioplasty (PTA) with or without stenting and Extracranial-Intracranial arterial bypass surgery has been reissued. This policy update affects coverage and billing requirements for these vascular procedures under Medicare Advantage plans.
Action Required
Before April 1, 2026: Billing team must review the complete policy MA11.056i for updated coverage criteria and billing requirements for PTA procedures with/without stenting and EC-IC arterial bypass surgery. Update prior authorization protocols and documentation requirements for Medicare Advantage plans as specified in the full policy.